The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A12 | Mineral supplements | |
| 3 | A12C | Other mineral supplements | |
| 4 | A12CB | Zinc |
| Code | Title | |
|---|---|---|
| A12CB01 | Zinc sulfate | |
| A12CB02 | Zinc gluconate | |
| A12CB03 | Zinc protein complex |
| Active Ingredient | Description | |
|---|---|---|
| Zinc |
Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells. |
|
| Zinc gluconate |
|
|
| Zinc sulfate |
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| SOLVAZINC Effervescent tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
